Agenda

7:00 a.m.

Registration and Continental Breakfast

8:00 a.m.

Welcome and Opening Remarks

8:15 a.m.

Fertility Preservation: Current Options to Protect Gametes From Toxic Therapies—What's Available, What's Reasonable
ACPE # 0453-9999-10-019-L01P (K)
David P. Cohen, MD, University of Chicago Medical Center

Recent advances in diagnostic and therapeutic methods in pediatric oncology have contributed to an 80 percent increase in survivorship. However, major long-term complications can occur that limit the quality of survival, including infertility. Treatments including chemotherapy, radiation therapy and surgery have been implicated as causes of infertility. With a goal of maximizing the survivor's quality of life, fertility preservation options for both prepubertal and pubescent males and females will be addressed.

9:00 a.m.

The Impact of Cancer During Pregnancy
ACPE # 0453-9999-10-020-L05P (K)
Kathryn J. Ruddy, MD, MPH, Dana-Farber Cancer Institute

Cancer is the second most common cause of death during the reproductive years and complicates up to one in 1,000 pregnancies. When cancer is diagnosed during pregnancy, the management strategy must take into account the health and safety of both the mother and developing fetus. This presentation will address methods of determining optimal cancer treatment strategies during pregnancy.

10:00 a.m.

Break

10:15 a.m.

Psychosocial Effects of Cancer
ACPE # 0453-9999-10-021-L01P (K)
Dianne M. Shumay, PhD,UCSF Helen Diller Family Comprehensive Cancer Center

Cancer is a life-changing experience for cancer patients, their friends and families. Cancer and cancer treatment both can have significant psychological and physiological effects on the patient. Although many aspects of quality of life after cancer have been previously studied, there are still gaps in our knowledge about the long-term effects of cancer survivors' and caregivers' physical, psychological, social and spiritual well-being. This presentation will address approaches to the management of psychosocial and other quality-of-life issues experienced by cancer patients and their caregivers.

11:00 a.m.

Evidence-Based Complementary and Alternative Medicine (CAM) Therapies: Indications, Contraindications and Opportunities
ACPE # 0453-9999-10-024-L04P (K)
Georgia M. Decker, APRN, ANP-BC, CN^®, AOCN^®, Integrative Care

Complementary and alternative medicine (CAM), as defined by the National Center for Complementary and Alternative Medicine (NCCAM), is a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. This presentation will explore complementary and alternative healing practices in the context of rigorous science, trained CAM researchers, and authoritative information offered to the public and professionals.

Noon

Lunch(provided)

1:00 p.m.

Palliative Care—More Than Hospice
ACPE # 0453-9999-10-023-L01P (K)
Sharon Weinstein, MD, Huntsman Cancer Institute at the University of Utah

The goal of palliative care is to improve—through a multidisciplinary approach aimed at the prevention and timely relief of all dimensions of suffering—the quality of life of patients and their families facing the challenges associated with a life-threatening illness. This presentation will discuss how the specialized services that comprise palliative care help families cope with difficult decisions and improve the patient's quality of life.

2:00 p.m.

Advances in Radiation Therapy
ACPE # 0453-9999-10-028-L05P (K)
Timothy Solberg, PhD, FAAPM, FACMP, UT Southwestern Medical Center

Recent advances in radiation therapy have improved effectiveness, decreased complications and expanded implications. Many of these novel approaches have improved radiation targeting, thereby limiting the exposure of healthy tissues to radiation, while producing excellent outcomes. This presentation will review recent innovations in radiation therapy, including how it is being utilized to treat a variety of cancers, and the future direction in this rapidly changing field.

3:00 p.m.

Break

3:15 p.m.

Survivorship and the Cancer Patient
ACPE # 0453-9999-10-022-L01P (K)
Michelle E. Melisko, MD, UCSF Helen Diller Family Comprehensive Cancer Center

Survivorship issues for cancer patients are of growing importance as advances in the treatment and detection of cancer have resulted in an estimated 12 million cancer survivors in the United States alone. However, cancer survivors need assistance navigating the varied and complex issues they face after treatment. This presentation reviews approaches to the management of cancer survivors that are aimed at maximizing the quality of life of this rapidly growing group of individuals.

4:00–5:00 p.m.

Increasing Awareness of Clinical Trials, Starting at Home
ACPE # 0453-9999-10-025-L04P (K)
Smitha S. Krishnamurthi, MD, University Hospitals Case Medical Center

Research has shown that the general public is either unaware of clinical trials as a treatment or prevention option or misinformed about the clinical trials process. Many barriers discourage potential participants from taking part in clinical trials. Education is one way to help reduce these barriers. This presentation will help increase awareness about the importance of clinical trials and enhance knowledge, attitudes, and beliefs about cancer clinical trials among health care professionals, cancer patients, and community members.

5:00–7:00 p.m.

COMPLIMENTARY GET-ACQUAINTED RECEPTION

Join your colleagues for hors d'oeuvres and beverages. You won't want to miss this opportunity to gather information and ideas from exhibitors regarding the management of complex medical conditions.

7:30 a.m.

Continental Breakfast

8:00 a.m.

Oral Chemotherapy: A Shifting Paradigm
ACPE # 0453-9999-10-027-L04P (K)
Sandhya Srinivas, MD, Stanford Cancer Center

Oral chemotherapy drug development has significantly increased during the past several years and is anticipated to continue to grow. A new generation of targeted therapies, many of them taken orally, have transformed cancer treatment for many patients. This presentation will address the challenges associated with oral treatment regimens for cancer patients.

9:00 a.m.

Pancreatic Cancer: Is There Hope on the Horizon?
ACPE # 0453-9999-10-031-L01P (K)
Martin J. Heslin, MD, University of Alabama Hospital at Birmingham

Pancreatic cancer is the fourth leading cause of death among both men and women, comprising 6 percent of all cancer-related deaths. The disease is usually aggressive and notoriously difficult to diagnose in its early stages. The survival rate of 5 percent has not improved significantly over the past two decades. This presentation will discuss recent developments in treating pancreatic cancer using newer chemotherapeutic and molecular-targeted agents, as well as outline treatment strategies that could lead to progress in the future.

9:45 a.m.

Break

10:00 a.m.

Advances in Renal Cell Carcinoma (RCC) in Adults: What are the Options?
ACPE # 0453-9999-10-029-L01P (K)
Roberto Pili, MD, Roswell Park Cancer Institute

RCC is the most common type of kidney cancer in adults, with occurrence rates rising steadily around the world. A proliferation of new treatment options for advanced RCC, a disease that is usually associated with a poor prognosis, have led to improved survival and quality of life for a significant number of patients. This presentation will discuss the current state-of-the-art therapies for advanced RCC.

11:00 a.m.

Prostate Cancer: Are We Over-treating this Disease?
ACPE # 0453-9999-10-030-L01P (K)
Laura E. Crocitto, MD, City of Hope

Prostate cancer is the second leading cause of cancer deaths in men. Some prostate cancers are slow-growing and may not need definitive treatment, while others are aggressive and will require treatment by one or more of the currently available modalities. This presentation will identify different ways of differentiating among these disparate groups of patients.

Noon

LUNCHEON PRESENTATION—An Overview of OptumHealth Care Solutions (optional)

OptumHealth features best-in-class programs and services in case management, disease management, treatment of complex medical conditions, decision support, physical medicine and wellness. Learn about the products and services available through OptumHealth that can help payers and employers aggressively manage costs while enhancing members'/employees' health and well-being.

1:30 p.m.

Advising Breast Cancer Patients About Healthy Lifestyle Behaviors
ACPE # 0453-9999-10-026-L04P (K)
Ann M. Berger, PhD, RN, AOCNS, FAAN, University of Nebraska Medical Center

Raising awareness about the impact people can have on their health status through adopting healthy lifestyles is a step toward cancer prevention. Healthy lifestyle behaviors encompassing weight management, a healthy diet, regular exercise, and smoking cessation have the potential to reduce morbidity and mortality significantly in cancer survivors. This presentation will  examine the efficacy of various intervention approaches to promote health behavior changes among breast cancer survivors.

2:30 p.m.

Strategies for Treating Liver Metastases From Colorectal Cancer
ACPE # 0453-9999-10-032-L01P (K)
Emily Chan, MD, PhD, Vanderbilt-Ingram Cancer Center

Hepatic metastases are a common complication of colorectal cancer. The appearance of liver metastases has long been regarded as a poor prognostic sign and is a leading cause of colorectal cancer-related morbidity and mortality. This presentation will discuss various therapeutic options that can be used for the treatment of colorectal cancer with liver metastases and highlight the progress that has been made in the last decade.

3:15 p.m.

Break

3:30 p.m.

Lung Cancer: Are We Winning the Fight?
ACPE # 0453-9999-10-033-L01P (K)
James D. Cox, MD, FACR, FASTRO, The University of Texas M.D. Anderson Cancer Center

Lung cancer is the leading cause of cancer death in both men and women. It constitutes one of the most serious public health problems for the country due to its high incidence and mortality rates. This presentation will review the latest treatment options for each stage of non-small-cell lung cancer, including newer targeted therapies that improve outcomes for some patients and lead to a more personalized treatment approach.

4:15–5:00 p.m.

Considerations in the Treatment of Multiple Myeloma (MM)
ACPE # 0453-9999-10-034-L01P (K)
Jonathan L. Kaufman, MD, Winship Cancer Center at Emory University

Treatment options for patients with MM have increased dramatically with the availability of a host of new agents. These drugs have not only improved response rates, but have significantly lengthened survival as well. This presentation will summarize some of the most promising combinations of novel agents used in induction therapy and briefly discuss the potential effect of additional emerging novel agents in the relapsed-disease setting.

7:30 a.m.

Continental Breakfast

8:00 a.m.

Management Strategies for Genetic Predisposition to Cancer
ACPE # 0453-9999-10-035-L01P (K)
Kim Nichols, MD, The Children's Hospital of Philadelphia

About 12,500 children under the age of 20 are diagnosed with cancer each year in the United States, and it is estimated that between 1 and 5 percent of these cancers have a hereditary basis. The latest advances in oncologic genetics can now provide care and counseling to improve the outlook for children with genetic predisposition to cancer. This presentation will review information about the diagnosis, course and management of genetic conditions associated with increased cancer risk.

8:45 a.m.

Neuroblastoma: Best and Worst of this Pediatric Cancer
ACPE # 0453-9999-10-036-L01P (K)
Meaghan P. Granger, MD, Cook Children's Medical Center

Neuroblastoma is the most common extracranial solid tumor in infancy. The differences in outcomes among patients with neuroblastoma are striking. Patients with low-risk and intermediate-risk neuroblastoma have an excellent prognosis; however, those with high-risk disease continue to have very poor outcomes despite intensive therapy. This presentation will outline criteria used for risk stratification and treatment of this complex disease.

9:30 a.m.

Break—Please use this extended break for hotel checkout if necessary.

10:00 a.m.

Management of Long-Term Issues and Implications of the Pediatric Cancer Patient
ACPE # 0453-9999-10-037-L04P (K)
Peter E. Manley, MD, Dana-Farber/Children's Hospital Cancer Care

As the number of pediatric cancer survivors increases, there have been increasing concerns about the long-term effects of their treatment. Just as the treatment of childhood cancer requires a very specialized approach, so does aftercare and monitoring for late effects. This presentation will discuss management strategies directed at these long-term issues that can materially affect the future health of the growing group of individuals.

10:45 a.m.

Pediatric Acute Leukemia: Successful Therapies and Their Promise for the Future
ACPE # 0453-9999-10-038-L01P (K)
Morris Kletzel, MD, Children's Memorial Hospital

Leukemia is the most common form of childhood cancer. With new and better therapies, survival rates for children have improved significantly during the last several decades. This presentation will discuss causes of childhood leukemia and treatments that are tailored to decrease the toxic effects of therapy and improve outcomes.

11:45 a.m.

Childhood Non-Hodgkin Lymphoma Treatment
ACPE # 0453-9999-10-039-L01P (K)
Edythe Albano, MD, The Children's Hospital, Denver

In the last decade, lymphoma treatment in children has become increasingly successful. Currently, the majority of children with non-Hodgkin lymphoma are disease-free. This presentation will review treatment advances that have markedly changed the outlook for the once uniformly fatal disease.

12:30 p.m.

Adjourn